HomeMNMD • NASDAQ
Mind Medicine (MindMed) Inc
add
$6.35
0.63%
After Hours:(1.92%)+0.12
$6.47
Closed: Mar 14, 7:12:23 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.46M | 46.19% |
Net income | -34.74M | -45.58% |
Net profit margin | — | — |
Earnings per share | -0.41 | 48.59% |
EBITDA | -32.46M | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 273.74M | 174.55% |
Total assets | 302.15M | 142.61% |
Total liabilities | 60.70M | 30.81% |
Total equity | 241.45M | — |
Shares outstanding | 75.37M | — |
Price to book | 1.97 | — |
Return on assets | -26.10% | — |
Return on capital | -29.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -34.74M | -45.58% |
Cash from operations | -25.35M | -23.28% |
Cash from investing | — | — |
Cash from financing | 3.81M | 46.82% |
Net change in cash | -21.54M | -19.72% |
Free cash flow | -13.99M | -36.15% |
Previous close
$6.31
Day range
$6.22 - $6.65
Year range
$5.05 - $12.22
Market cap
465.66M USD
Avg Volume
2.69M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Mind Medicine Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
Founded
2010
Website
Employees
74
